//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
ProfilePosts









Loading...
Calling all SmartBatch+ users! Have you validated a new antibody or tissue type? Send us proof and receive: šŸ‘‰ 15% off your next reagent order for 1 new validation šŸ‘‰ 25% off for 2+ validations šŸ‘‰ A chance to be featured in our User Newsletter šŸ“† Submit your data by June 17th: bit.ly/4ekYzsj
How can we get gene therapies to the heart more safely & effectively? šŸ«€ A research team led by Daniel Siegwart & Eric Olson at the UT Southwestern Medical Center has developed optimized lipid nanoparticles (LNPs) that demonstrate robust, targeted mRNA delivery & therapeutic potential 🧵 (1/3)
10d
12d
Video
LifeCanvas Technologies
LifeCanvas Technologies
Yehui Sun & Yu-Chung Pien et al. screened LNPs using human iPSC-derived cardiomyocytes, then used Clear+ tissue clearing with #SmartSPIM lightsheet microscopy to characterize biodistribution of their lead candidate throughout the whole mouse heart. (2/3)
4d
10d
šŸ“½ļø SYFP2 expression data from Dr. Tanya Daigle & Emily Kussick, imaged with #SmartSPIM!